# US 2022/0364062 A1 · Production bacterial cells and use thereof in production methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0364062 A1
- Document ID: US20220364062A1
- Status: Published application
- Kind: A1
- Application number: 17/742,671
- Filed: 2022-05-12
- Published: 2022-11-17
- Earliest claimed: 2021-05-12
- Assignees: Eligo Bioscience
- Applicants: Eligo Bioscience
- Inventors: Jesus FERNANDEZ RODRIGUEZ; Antoine DECRULLE; Aymeric LEVEAU; Ines CANADAS BLASCO; Aurélie MATHIEU; Thibault CARLIER
- Web page: https://patentgrep.com/patent/US20220364062A1

## CPC

- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 1/20: Bacteria; Culture media therefor
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N 15/86: Viral vectors
- C12N 2795/00021: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2795/00043: viral genome or elements thereof as genetic vector
- C12N 2795/00044: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
- C12N 2795/00052: relating to complementing cells and packaging systems for producing virus or viral particles
- C12N 2795/10221: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2795/10243: viral genome or elements thereof as genetic vector
- C12N 2795/10252: relating to complementing cells and packaging systems for producing virus or viral particles
- C12N 2795/10321: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2795/10322: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2795/10343: viral genome or elements thereof as genetic vector
- C12N 2795/10344: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
- C12N 2795/10352: relating to complementing cells and packaging systems for producing virus or viral particles
- C12N 2800/101: for bacteria
- C12N 2800/40: Systems of functionally co-operating vectors
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention concerns a production bacterial cell for producing phage particles or phage-derived delivery vehicles, said production bacterial cell stably comprising at least one phage structural gene(s) and at least one phage DNA packaging gene(s), said phage structural gene(s) and phage DNA packaging gene(s) being derived from a first type of bacteriophage, wherein the expression of at least one of said phage structural gene(s) and/or at least one of said phage DNA packaging gene(s) in said production bacterial cell is controlled by at least one induction mechanism, and wherein said production bacterial cell is from a bacterial species or strain different from the bacterial species or strain from which said first type of bacteriophage comes and/or that said first type of bacteriophage targets.

## Claims

### Claim 1

Production bacterial cell for producing phage particles or phage-derived delivery vehicles, said production bacterial cell stably comprising at least one phage structural gene and at least one phage DNA packaging gene, said phage structural gene(s) and phage DNA packaging gene(s) being derived from a first type of bacteriophage,
wherein the expression of at least one of said phage structural gene(s) and/or at least one of said phage DNA packaging gene(s) in said production bacterial cell is controlled by at least one induction mechanism, and
wherein said production bacterial cell is from a bacterial species or strain different from the bacterial species or strain from which said first type of bacteriophage comes from and/or that said first type of bacteriophage targets.

### Claim 2 (depends on 1)

The production bacterial cell according to claim 1, wherein said bacterial cell further comprises a payload to be packaged into said phage particles or phage-derived delivery vehicles.

### Claim 3 (depends on 2)

The production bacterial cell according to claim 2, wherein said payload is a nucleic acid payload comprising a packaging site derived from said first type of bacteriophage.

### Claim 4 (depends on 2)

The production bacterial cell according to claim 2, wherein said payload is to be delivered into targeted bacterial cells.

### Claim 5 (depends on 4)

The production bacterial cell according to claim 4, wherein said payload comprises a sequence of interest.

### Claim 6 (depends on 5)

The production bacterial cell according to claim 5, wherein said sequence of interest only generates an effect in said targeted bacterial cells.

### Claim 7 (depends on 6)

The production bacterial cell according to claim 6, wherein said targeted bacterial cells are from a species or strain different from the production bacterial cell.

### Claim 8 (depends on 1)

The production bacterial cell according to claim 1, wherein the same induction mechanism controls the expression of the at least one of said phage structural gene(s) and the at least one of said phage DNA packaging gene(s).

### Claim 9 (depends on 1)

The production bacterial cell according to claim 1, wherein the expression of the at least one of said phage structural gene(s) and the expression of the at least one of said phage DNA packaging gene(s) are controlled by different induction mechanisms.

### Claim 10 (depends on 1)

The production bacterial cell according to claim 1, wherein the at least one induction mechanism controls the expression of all said phage structural gene(s).

### Claim 11 (depends on 1)

The production bacterial cell according to claim 1, wherein the at least one induction mechanism controls the expression of all said phage DNA packaging gene(s).

### Claim 12 (depends on 1)

The production bacterial cell according to claim 1, wherein said phage structural gene(s) and phage DNA packaging gene(s) derived from said first type of bacteriophage are comprised in at least one plasmid, chromosome, and/or helper phage.

### Claim 13 (depends on 1)

The production bacterial cell according to claim 1, wherein said production bacterial cell further comprises at least one gene, derived from a second type of bacteriophage, involved in phage excision/insertion, phage DNA replication, and/or phage regulation,
said second type of bacteriophage coming from and/or targeting bacterial species or strain different from the bacterial species or strain from which said first type of bacteriophage comes from and/or that said first type of bacteriophage targets.

### Claim 14 (depends on 13)

The production bacterial cell according to claim 13, wherein said production bacterial cell is from the same bacterial species or strain as the bacterial species or strain from which said second type of bacteriophage comes from and/or that said second type of bacteriophage targets.

### Claim 15 (depends on 1)

The production bacterial cell according to claim 1, wherein said production bacterial cell is an E. coli bacterial cell.

### Claim 16 (depends on 1)

The production bacterial cell according to claim 1, wherein said production bacterial cell is a P. freudenreichii bacterial cell.

### Claim 17 (depends on 16)

The production bacterial cell according to claim 16, wherein the bacterial species or strain from which said first type of bacteriophage comes from and/or that said first type of bacteriophage targets is C. acnes.

### Claim 18

A method for producing phage particles or phage-derived delivery vehicles, comprising:
(a) providing a production bacterial cell for producing phage particles or phage-derived delivery vehicles, said production bacterial cell stably comprising at least one phage structural gene and at least one phage DNA packaging gene, said phage structural gene(s) and phage DNA packaging gene(s) being derived from a first type of bacteriophage,
wherein the expression of at least one of said phage structural gene(s) and/or at least one of said phage DNA packaging gene(s) in said production bacterial cell is controlled by at least one induction mechanism, and
wherein said production bacterial cell is from a bacterial species or strain different from the bacterial species or strain from which said first type of bacteriophage comes from and/or that said first type of bacteriophage targets,
and
(b) inducing, in said production bacterial cell, expression of said at least one of said phage structural gene(s) and said at least one of said phage DNA packaging gene(s), and assembly of the products expressed by said at least one phage structural gene(s) and said at least one phage DNA packaging gene(s), thereby producing phage particles or phage-derived delivery vehicles.

### Claim 19

Hybrid helper phage system comprising:
(i) at least one phage DNA packaging gene(s) derived from a first type of bacteriophage,
(i′) at least one phage structural gene(s) derived from said first type of bacteriophage, and
(ii) at least one gene, derived from a second type of bacteriophage, involved in phage excision/insertion, phage DNA replication, and/or phage regulation,
wherein said genes (i), (i′) and (ii) are comprised in a unique nucleic acid molecule or in separate nucleic acid molecules,
wherein said first type of bacteriophage comes from and/or target bacterial species or strain different from the bacterial species or strain from which said second type of bacteriophage comes from and/or that said second type of bacteriophage targets, and
wherein said hybrid helper phage system does not comprise any expressed phage structural gene derived from said second type of bacteriophage.

### Claim 20 (depends on 19)

The hybrid helper phage system according to claim 19, wherein said genes (i), (i′) and (ii) are comprised in a bacterial chromosome.

### Claim 21 (depends on 19)

The hybrid helper phage system according to claim 19, wherein said genes (i), (i′) and (ii) are comprised in separate plasmids.

### Claim 22 (depends on 19)

The hybrid helper phage system according to claim 19, wherein said hybrid helper phage system consists of a hybrid helper phage comprising:
(i) at least one phage DNA packaging gene(s) and at least one phage structural gene(s) derived from a first type of bacteriophage, and
(ii) at least one gene, derived from a second type of bacteriophage, involved in phage excision/insertion, phage DNA replication, and/or phage regulation,
wherein said first type of bacteriophage comes from and/or target bacterial species or strain different from the bacterial species or strain from which said second type of bacteriophage comes from and/or that said second type of bacteriophage targets, and
wherein said hybrid helper phage does not comprise any expressed phage structural gene derived from said second type of bacteriophage.

### Claim 23

Production bacterial cell for producing tailocin and/or pyocin, said production bacterial cell stably comprising at least one tailocin and/or pyocin structural gene(s) derived from a bacterial species or strain containing tailocin and/or pyocin genes,
wherein the expression of at least one of said tailocin and/or pyocin structural gene(s) in said production bacterial cell is controlled by at least one induction mechanism, and
wherein said production bacterial cell is from a bacterial species or strain different from the bacterial species or strain containing tailocin and/or pyocin genes from which said tailocin and/or pyocin structural gene(s) is derived.

### Claim 24 (depends on 23)

The production bacterial cell according to claim 23, wherein said tailocin and/or pyocin is intended to lyse targeted bacterial cells.

### Claim 25 (depends on 23)

The production bacterial cell according to claim 23, wherein said targeted bacterial cells are from a species or strain different from the production bacterial cell.

### Claim 26 (depends on 23)

The production bacterial cell according to claim 23, wherein the at least one induction mechanism controls the expression of all said tailocin and/or pyocin structural gene(s).

### Claim 27 (depends on 23)

The production bacterial cell according to claim 23, wherein said at least one induction mechanism further controls the copy number of said at least one of said tailocin and/or pyocin structural gene(s).

### Claim 28 (depends on 23)

The production bacterial cell according to claim 23, wherein said tailocin and/or pyocin structural gene(s) are comprised in at least one plasmid, chromosome, and/or helper phage.

### Claim 29 (depends on 23)

The production bacterial cell according to claim 23, wherein said production bacterial cell further comprises at least one gene, derived from a bacteriophage, involved in phage excision/insertion, phage DNA replication, and/or phage regulation,
said bacteriophage coming from and/or targeting bacterial species or strain different from the bacterial species or strain from which said tailocin and/or pyocin structural gene(s) is derived.

### Claim 30 (depends on 23)

The production bacterial cell according to claim 23, wherein said production bacterial cell is an E. coli bacterial cell.
